Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients
For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia.
Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry. His appointment by Dean B. Joseph Guglielmo, PharmD, will be effective January 15, 2016.
New computer models were able to successfully predict negative side effects for hundreds of currently marketed drugs, report researchers from the UCSF School of Pharmacy, SeaChange Pharmaceuticals, and Novartis Institutes for Biomedical Research in a paper published online this week in the journal...
Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.
The fellowship, which supports “highly creative professors early in their careers,” provides an unrestricted research...
Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and...
The new UCSF Center for Quantitative Pharmacology housed within the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the Schools of Pharmacy and Medicine, will be inaugurated next week with a wide-ranging, 2-day conference, September 22 and 23, 2011 at William J. ...
The bacteria in the human gut that produce antibiotics are the focus of a US$1 million W. M. Keck Foundation grant being led by Michael Fischbach, PhD, a faculty member in the UCSF School of Pharmacy.
Michael Fischbach, PhD, is the recipient of a 2010 NIH Director’s New Innovator Award from the National Institutes of Health. Fischbach is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine.
Through study results of a particular enzyme of unknown function, called Tm0936, that is found in a bacterium that lives in thermal vents in the Mediterranean Ocean, UCSF School of Pharmacy faculty member Brian Shoichet, PhD and colleagues are shedding light on how to ultimately better predict the...
The Center for Drug Development Science (CDDS), located in Washington, DC, has joined with the UCSF School of Pharmacy to advance the safe and effective use of drugs.